Loading company…
Radius Health develops and commercializes medicines for osteoporosis and other bone health conditions.
Founded in 2003, Radius Health develops treatments for bone health, including TYMLOS® for osteoporosis and BINOSTO® for osteoporosis treatment. The company is based in Boston, US. In 2022, it transitioned from public to private ownership, raising a total of USD 849.78 million from Gurnet Point Capital and Patient Square Capital. In March 2026, it merged with Paratek Pharmaceuticals, with Sixth Street and Blackstone providing USD 1.3 billion in debt financing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in